Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki T
Division of Pharmacobio-dynamics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo.
Jpn J Cancer Res. 1999 Sep;90(9):899-902. doi: 10.1111/j.1349-7006.1999.tb00832.x.
Interindividual variability of the activity of CYP1A2 may be expected to affect cancer susceptibility, since the enzyme is capable of activating several carcinogens. In the present study, we found three new polymorphisms in the 5'-flanking region (CYPIA2/B) and intron 1 (CYPIA2/C and CYP1A2/D) of CYP1A2 in Japanese by using polymerase chain reaction-single strand conformation polymorphism. We developed methods to detect these polymorphisms by polymerase chain reaction-restriction fragment length polymorphism and performed a population study (159 subjects) to estimate the frequencies of the alleles. The frequencies of the CYP1A2/A (adenine), CYP1A2/B (thymine-deleted), CYP1A2/C (guanine) and CYP1A2/D (adenine) variants were 21.1, 42.0, 8.2 and 61.3%, respectively. The results of family study supported the idea that these CYP1A2 genotypes are inherited with an autosomal codominant transmission.
由于细胞色素P450 1A2(CYP1A2)能够激活多种致癌物,其活性的个体间差异可能会影响癌症易感性。在本研究中,我们利用聚合酶链反应-单链构象多态性方法,在日本人的CYP1A2基因5'-侧翼区(CYPIA2/B)和第1内含子(CYPIA2/C和CYP1A2/D)中发现了三个新的多态性位点。我们开发了通过聚合酶链反应-限制性片段长度多态性检测这些多态性的方法,并进行了一项群体研究(159名受试者)以估计等位基因频率。CYP1A2/A(腺嘌呤)、CYP1A2/B(胸腺嘧啶缺失)、CYP1A2/C(鸟嘌呤)和CYP1A2/D(腺嘌呤)变异体的频率分别为21.1%、42.0%、8.2%和61.3%。家系研究结果支持这些CYP1A2基因型以常染色体共显性方式遗传的观点。